We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Owes $192M For Cancer Drug Rights, Rival Says

Law360 (March 19, 2018, 10:28 PM EDT) -- AstraZeneca owes $192 million for refusing to pay royalties for an Array cancer drug after entering an $8.5 billion collaboration with Merck to develop and commercialize the compound, according to a lawsuit...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New York Southern

Nature of Suit

190(Contract: Other)

Date Filed

January 11, 2018


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New York Southern

Nature of Suit

Contract: Other

Judge

Subscribers Only

Date Filed

March 19, 2018

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.